Vanessa Stadlbauer-Köllner | The gut-liver axis as a novel therapeutic target in chronic liver disease

Vanessa Stadlbauer-Köllner | The gut-liver axis as a novel therapeutic target in chronic liver disease

– Learn background information on the burden of chronic liver disease and on gut microbiome composition
– Understand the alterations in the gut-liver axis in chronic liver diseases
– Discover methods …


When
1st May 2019

This content is for practitioners only

Please create an account and login to view this educational resource.

Login / Register

Related Articles


Bio.Me, Bio.Me Barrier, Gastrointestinal
Looking for a product to support gut barrier function?

When is barrier function a relevant clinical consideration? The importance of an effective physical and immune barrier at the site of host-microbiome interactions cannot be downplayed. Our solution is Bio....

Bio.Me, Women's Health
Vaginal Microbiome Probiotic: Bio.Me Femme V

Bio.Me™ Femme V - Our vaginal health probiotic containing keystone Lactobacillus species

Bio.Me, Bio.Me Oral, Oral EcologiX™, Oral Health
The Oral Microbiome | Strain Specific Research

Probiotic strains have very specific functions and should be chosen accordingly. Additionally, some strains should not be put together in capsules or powder due to their incompatibility. It is a ...